No Detail Found!

Frequency of Systemic Risk Factors in Central Serous Chorioretinopathy.

Author(s)
Qamar Ul Islam Department of Eye, PNS Shifa Naval Hospital, Karachi, Pakistan
Muhammad Kashif Hanif Department of Eye, Combined Military Hospital, Nowshera, Pakistan
Sheraz Tareen Department of Eye, Armed Forces Institute of Ophthalmology (AFIO), Rawalpindi, Pakistan
Abstract
Objective: To determine the frequency of various systemic risk factors associated with acute central serous chorioretinopathy (CSCR) in our setup. Study Design: Descriptive case series. Place and Duration of Study: Armed Forces Institute of Ophthalmology (AFIO), Rawalpindi, from July 2011 to June 2014. Methodology: All consecutive patients with acute CSCR who presented in the outpatient department during the study period were recruited. Clinical findings were endorsed on a pre-devised proforma with special emphasis on inquiring about known systemic risk factors for CSCR in detail from each patient. Patients were managed conservatively with control of modifiable risk factors and topical 0.1% Nepafenac eye drops. Analysis of data was done using SPSS version 13.0. Results: Forty-four eyes of 42 patients were eligible for final analysis. The mean age of study population was 37.38 ±6.31 years with 38 (90.47%) male patients. Elevated serum cortisol and serum testosterone levels were found in 3 and 2 patients, respectively. Known systemic risk factors for CSCR were present in 36 (85.71%) patients with emotional stress/psychiatric disorder 15 (35.71%), Type A personality 11 (26.19%), smoking 10 (19.04%), hypertension 5 (11.90%), and acid peptic disease 4 (9.52%) were the most frequently found risk factors. Conclusion: Emotional stress/psychiatric illness, hypertension, acid peptic disease and use of exogenous steroids and other medicines are the established risk factors for CSCR that can be modified/withdrawn to reduce the morbidity related to CSCR.
Publication Details
Page(s) 692-695
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 26, Issue: 8, Year: 2016

Request the full text from PASTIC

Keywords
Central serous chorioretinopathy. Risk factors. Retinal diseases. Fluorescein angiography. Central serous retinopathy
References
RoshaniM,Ahangar DavoodiN,Seyed MajidiMR,ZojajiH,Jahani-SherafatS,HashemiM, 2014.Association of Helicobacter pylori with central serous chorioretinopathy in Iranian patients,Gastroenterol Hepatol Bed Bench 7 63 -7
DangY,MuY,ZhaoM,LinL,GuoY,ZhuY., 2013.The effect of eradicating Helicobacter pylori on idiopathic central serous chorioretinopathy patients,Ther Clin Risk Manag 9 355 -60
ShahinMM, 2013.Angiographic characteristics of central serous chorioretinopathy in an Egyptian population,Int J Ophthalmol 6 342 -5
LieglR,UlbigMW, 2014.Central serous chorioretinopathy,Ophthalmologica 232 65 -76
LiewG,QuinG,GilliesM,Fraser-Bell S, 2013.Central serous chorioretinopathy: A review of epidemiology and pathophysiology,Clin Experiment Ophthalmol 41 201 -14
EomY,OhJ,KimSW,HuhK., 2012.Systemic factors associated with central serous chorioretinopathy in Koreans,Korean J Ophthalmol 26 260 -64
ZakirSM,ShuklaM,SimiZ,AhmadJ,SajidM., 2009.Serum cortisol and testosterone levels in idiopathic central serous chorioretinopathy,Indian J Ophthalmol 57 419 -22
JamilAZ,MirzaKA,QaziZA,IqbalW,KhaliqJ,RahmanF, 2013.Features of central serous chorioretinopathy presenting at a tertiary care hospital in Lahore,J Pak Med Assoc 63 478 -82
QadirA,ShahSA,MuradY, 2011.Factors associated with central serous chorioretinopathy in our setup,Ophthalmology Update 9 7 -10
JamilAZ,RahmanF,IqbalK,AnsariHM,IqbalW,MirzaKA, 2012.Intra-vitreal Bevacizumab in central serous chorioretinopathy,J Coll Physicians Surg Pak 22 363 -6
EliasA,GopalakrishnanM,NairD,BhatS,GudapatiR,AnantharamanG., 2011.A 10-year study of central serous chorioretinopathy: Recurrence rate and factors affecting recurrence,World J Retin Vitreous 1 69 -74
HowA,KohA, 2006.Angiographic characteristics of acute central serous chorioretinopathy in an Asian population,Ann Acad Med Singapore 35 77 -9
ConradR,GeiserF,KleimanA,ZurB,Karpawitz-GodtA, 2014.Temperament and character personality profile and illnessrelated stress in central serous chorioretinopathy,Sci World J -
SahinA,BezY,KayaMC,TürkcüFM,SahinM,Yüksel H, 2014.Psychological distress and poor quality of life in patients with central serous chorioretinopathy,Semin Ophthalmol 29 73 -6
BazzaziN,AhmadpanahM,AkbarzadehS,Seif RabieiMA,Holsboer-TrachslerE,BrandS., 2015.In patients suffering from idiopathic central serous chorioretinopathy, anxiety scores are higher than in healthy controls, but do not vary according to sex or repeated central serous chorioretinopathy,Neuropsychiatr Dis Treat 11 1131 -6
Mateo-MontoyaA,Mauget-FaÿseM, 2014.Helicobacter pylori as a risk factor for central serous chorioretinopathy: Literature review,World J Gastrointest Pathophysiol 5 355 -8
KaradimasP,BouzasEA, 2004.Glucocorticoid use represents a risk factor for central serous chorioretinopathy: A prospective, case-control study,Graefes Arch Clin Exp Ophthalmol 242 800 -2
TsaiDC,ChenSJ,HuangCC,ChouP,ChungCM,ChanWL, 2014.Risk of central serous chorioretinopathy in adults prescribed oral corticosteroids,Retina 34 1867 -74
AliferisK,PetropoulosIK,FarpourB,MatterMA,SafranAB, 2012.Should central serous chorioretinopathy be added to the list of ocular side effects of phosphodiesterase 5 inhibitors?,Ophthalmologica 227 85 -9
FraunfelderFW,FraunfelderFT, 2008.Central serous chorioretinopathy associated with Sildenafil,Retina 28 606 -9
0

Citations

0

Downloads

110

Views